...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: RVXOT
Reply New Message
Back To Forum List View
RVXOT
3
KOO-KOO2
May 05, 2020 06:31PM
Re: RVXOT
2
RVXoldtimer
May 05, 2020 09:01PM

RVXOT does the following link makes any sense to you?

https://www.theglobeandmail.com/investing/markets/stocks/ZENI-P-X/

Note the description:

"DESCRIPTION

Zenith Capital Corp is a clinical stage biotechnology company. It develops bromodomain and extraterminal domain protein (BET) inhibitors for the treatment of cancer and other disorders with unmet medical need. Its pipeline product ZEN-3694, will help for the treatment of metastatic castration resistant prostate cancer."

 

Koo

1 Recommendations
Re: RVXOT
1
RVXoldtimer
May 06, 2020 11:02AM
Re: RVXOT
1
KOO-KOO2
May 06, 2020 11:13AM
Re: RVXOT
1
RVXoldtimer
May 06, 2020 11:59AM
Re: RVXOT
1
Telepanel
May 06, 2020 01:36PM
Re: RVXOT
1
RVXoldtimer
May 06, 2020 02:32PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply